Logo image of BLFS

BIOLIFE SOLUTIONS INC (BLFS) Stock Price, Quote, News and Overview

NASDAQ:BLFS - Nasdaq - US09062W2044 - Common Stock - Currency: USD

25.27  +0.67 (+2.72%)

After market: 25.27 0 (0%)

BLFS Quote, Performance and Key Statistics

BIOLIFE SOLUTIONS INC

NASDAQ:BLFS (5/2/2025, 8:00:01 PM)

After market: 25.27 0 (0%)

25.27

+0.67 (+2.72%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High29.55
52 Week Low17.15
Market Cap1.20B
Shares47.50M
Float46.18M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08/amc
IPO11-22 1989-11-22


BLFS short term performance overview.The bars show the price performance of BLFS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

BLFS long term performance overview.The bars show the price performance of BLFS in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of BLFS is 25.27 USD. In the past month the price increased by 12.61%. In the past year, price increased by 40.16%.

BIOLIFE SOLUTIONS INC / BLFS Daily stock chart

BLFS Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 19.34 159.89B
DHR DANAHER CORP 26.72 142.45B
A AGILENT TECHNOLOGIES INC 20.46 30.97B
IQV IQVIA HOLDINGS INC 13.78 27.06B
MTD METTLER-TOLEDO INTERNATIONAL 27.19 22.92B
WAT WATERS CORP 29.52 20.85B
WST WEST PHARMACEUTICAL SERVICES 31.82 15.18B
ILMN ILLUMINA INC 31.79 12.33B
ICLR ICON PLC 10.42 11.80B
RVTY REVVITY INC 19.06 11.29B
TEM TEMPUS AI INC N/A 9.87B
QGEN QIAGEN N.V. 19.52 9.32B

About BLFS

Company Profile

BLFS logo image BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 159 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

Company Info

BIOLIFE SOLUTIONS INC

Suite 310, 3303 Monte Villa Parkway

Bothell WASHINGTON 98021 US

CEO: Michael Rice

Employees: 159

BLFS Company Website

BLFS Investor Relations

Phone: 14254011400

BIOLIFE SOLUTIONS INC / BLFS FAQ

What is the stock price of BIOLIFE SOLUTIONS INC today?

The current stock price of BLFS is 25.27 USD. The price increased by 2.72% in the last trading session.


What is the ticker symbol for BIOLIFE SOLUTIONS INC stock?

The exchange symbol of BIOLIFE SOLUTIONS INC is BLFS and it is listed on the Nasdaq exchange.


On which exchange is BLFS stock listed?

BLFS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIOLIFE SOLUTIONS INC stock?

15 analysts have analysed BLFS and the average price target is 31.96 USD. This implies a price increase of 26.47% is expected in the next year compared to the current price of 25.27. Check the BIOLIFE SOLUTIONS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOLIFE SOLUTIONS INC worth?

BIOLIFE SOLUTIONS INC (BLFS) has a market capitalization of 1.20B USD. This makes BLFS a Small Cap stock.


How many employees does BIOLIFE SOLUTIONS INC have?

BIOLIFE SOLUTIONS INC (BLFS) currently has 159 employees.


What are the support and resistance levels for BIOLIFE SOLUTIONS INC (BLFS) stock?

BIOLIFE SOLUTIONS INC (BLFS) has a support level at 24.49 and a resistance level at 27.78. Check the full technical report for a detailed analysis of BLFS support and resistance levels.


Is BIOLIFE SOLUTIONS INC (BLFS) expected to grow?

The Revenue of BIOLIFE SOLUTIONS INC (BLFS) is expected to decline by -9.4% in the next year. Check the estimates tab for more information on the BLFS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOLIFE SOLUTIONS INC (BLFS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOLIFE SOLUTIONS INC (BLFS) stock pay dividends?

BLFS does not pay a dividend.


When does BIOLIFE SOLUTIONS INC (BLFS) report earnings?

BIOLIFE SOLUTIONS INC (BLFS) will report earnings on 2025-05-08, after the market close.


What is the Price/Earnings (PE) ratio of BIOLIFE SOLUTIONS INC (BLFS)?

BIOLIFE SOLUTIONS INC (BLFS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.51).


What is the Short Interest ratio of BIOLIFE SOLUTIONS INC (BLFS) stock?

The outstanding short interest for BIOLIFE SOLUTIONS INC (BLFS) is 8.29% of its float. Check the ownership tab for more information on the BLFS short interest.


BLFS Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to BLFS. When comparing the yearly performance of all stocks, BLFS is one of the better performing stocks in the market, outperforming 88.57% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BLFS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BLFS. No worries on liquidiy or solvency for BLFS as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BLFS Financial Highlights

Over the last trailing twelve months BLFS reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 55.65% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.05%
ROE -5.78%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%186.67%
Sales Q2Q%-30.61%
EPS 1Y (TTM)55.65%
Revenue 1Y (TTM)-42.59%

BLFS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to BLFS. The Buy consensus is the average rating of analysts ratings from 15 analysts.

For the next year, analysts expect an EPS growth of 73% and a revenue growth -9.4% for BLFS


Ownership
Inst Owners102.53%
Ins Owners1.69%
Short Float %8.29%
Short Ratio7.82
Analysts
Analysts82.67
Price Target31.96 (26.47%)
EPS Next Y73%
Revenue Next Year-9.4%